P.A.W. Capital Corp Uni Qure N.V. Transaction History

P.A.W. Capital Corp

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$29.97 - $37.17 $899,100 - $1.12 Million	-30,000 Closed	0 $0
Q1 2021 May 10, 2021	BUY	$29.24 - $42.03 $877,200 - $1.26 Million	30,000 New	30,000 $1.01 Million
Q3 2020 Nov 09, 2020	SELL	$35.98 - $47.66 $647,640 - $857,879	-18,000 Closed	0 $0
Q2 2020 Jul 27, 2020	SELL	$45.06 - $67.74 $1.44 Million - $2.17 Million	-32,000 Reduced 64.0%	18,000 $811,000
Q1 2020 May 08, 2020	BUY	$40.01 - $73.97 $400,100 - $739,700	10,000 Added 25.0%	50,000 $2.37 Million
Q4 2019 Jan 28, 2020	SELL	$37.13 - $74.62 $445,560 - $895,440	-12,000 Reduced 23.08%	40,000 $2.87 Million
Q2 2019 Jul 31, 2019	SELL	$52.76 - $82.19 $158,280 - $246,570	-3,000 Reduced 5.45%	52,000 $4.06 Million
Q4 2018 Feb 06, 2019	BUY	$22.8 - $33.93 $342,000 - $508,950	15,000 Added 37.5%	55,000 $1.59 Million
Q3 2018 Oct 24, 2018	BUY	$29.75 - $43.08 $148,750 - $215,400	5,000 Added 14.29%	40,000 $1.46 Million
Q2 2018 Jul 25, 2018	SELL	$21.96 - $39.94 $219,600 - $399,400	-10,000 Reduced 22.22%	35,000 $1.32 Million
Q1 2018 Apr 26, 2018	SELL	$17.1 - $26.61 $598,500 - $931,350	-35,000 Reduced 43.75%	45,000 $1.06 Million
Q4 2017 Jan 31, 2018	SELL	$9.47 - $19.59 $236,750 - $489,750	-25,000 Reduced 23.81%	80,000 $1.57 Million
Q3 2017 Oct 23, 2017	BUY	$7.7 - $9.6 $808,500 - $1.01 Million	105,000	105,000 $1.01 Million

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of P.A.W. Capital Corp, based on Form 13F filings with the SEC.

Stay updated on P.A.W. Capital Corp with notifications on news.